EPIdemiology of Surgery-Associated Acute Kidney Injury (EPIS-AKI) : Study protocol for a multicentre, observational trial

More than 300 million surgical procedures are performed each year. Acute kidney injury (AKI) is a common complication after major surgery and is associated with adverse short-term and long-term outcomes. However, there is a large variation in the incidence of reported AKI rates. The establishment of an accurate epidemiology of surgery-associated AKI is important for healthcare policy, quality initiatives, clinical trials, as well as for improving guidelines. The objective of the Epidemiology of Surgery-associated Acute Kidney Injury (EPIS-AKI) trial is to prospectively evaluate the epidemiology of AKI after major surgery using the latest Kidney Disease: Improving Global Outcomes (KDIGO) consensus definition of AKI. EPIS-AKI is an international prospective, observational, multicentre cohort study including 10 000 patients undergoing major surgery who are subsequently admitted to the ICU or a similar high dependency unit. The primary endpoint is the incidence of AKI within 72 hours after surgery according to the KDIGO criteria. Secondary endpoints include use of renal replacement therapy (RRT), mortality during ICU and hospital stay, length of ICU and hospital stay and major adverse kidney events (combined endpoint consisting of persistent renal dysfunction, RRT and mortality) at day 90. Further, we will evaluate preoperative and intraoperative risk factors affecting the incidence of postoperative AKI. In an add-on analysis, we will assess urinary biomarkers for early detection of AKI. EPIS-AKI has been approved by the leading Ethics Committee of the Medical Council North Rhine-Westphalia, of the Westphalian Wilhelms-University Münster and the corresponding Ethics Committee at each participating site. Results will be disseminated widely and published in peer-reviewed journals, presented at conferences and used to design further AKI-related trials. Trial registration number NCT04165369

Siloxane-Inorganic Chemical Crosslinking of 1 Hyaluronic Acid – Based Hybrid Hydrogels: Structural Characterization

HA-based hybrid hydrogels were successfully developed. The polysaccharide (HA) chains were chemically modified and hybridized via amidation of their carboxylic groups with aminosilane molecules. HA-polysaccharide chains were crosslinked by a 3D siloxane organic-inorganic matrix via sol-gel. The novel inorganic crosslinking network provided to sodium hyaluronate (HA) strong chemical bonds, giving restriction to their natural hydrophilicity and stiffness to its structure (improved rheological properties). It was observed that synthesis conditions such as starting HA concentration solution and temperature determined gelling times, efficiency in the polysaccharide chemical modification and in crosslinking hydrolysis-condensation reactions, resulting in the siloxane organic-inorganic matrix. Drying processes influenced crosslinking in HA hybrid hydrogels, either by enhancing polycondensation reactions or inhibiting them. Room temperature-drying produced more densified hybrid structures. Freeze-drying increased porosity and surface hydroxyl groups resulting in more structural units. 60 °C-drying boosted polycondensation of monodendate structural units, enhancing the formation of hybrid bonds.Peer reviewe

Consideraciones de caracterización de una celda de combustible con electrodos de grafito platino y membrana de intercambio protónico PEM

The characteristic V-I are studied in conditions variables of pressure and temperature, in presence of humidity and injection of gases Hydrogen and air with proton of exchange membrane fuel cell polymers (PEMFC), developed in the laboratory of the line of Electrochemistry in the National University of Colombia- Medellín.Se estudian las características V-I en condiciones variables de presión y temperatura, en presencia de humedad e inyección de gases Hidrógeno y aire en una celda de combustible con membrana polimérica de intercambio protónico (PEMFC), desarrollada en el laboratorio de la línea de profundización de Electroquímica en la Universidad Nacional de Colombia sede Medellín

EPIdemiology of Surgery-Associated Acute Kidney Injury (EPIS-AKI): Study protocol for a multicentre, observational trial

Introduction More than 300 million surgical procedures are performed each year. Acute kidney injury (AKI) is a common complication after major surgery and is associated with adverse short-term and long-term outcomes. However, there is a large variation in the incidence of reported AKI rates. The establishment of an accurate epidemiology of surgery-associated AKI is important for healthcare policy, quality initiatives, clinical trials, as well as for improving guidelines. The objective of the Epidemiology of Surgery-associated Acute Kidney Injury (EPIS-AKI) trial is to prospectively evaluate the epidemiology of AKI after major surgery using the latest Kidney Disease: Improving Global Outcomes (KDIGO) consensus definition of AKI. Methods and analysis EPIS-AKI is an international prospective, observational, multicentre cohort study including 10 000 patients undergoing major surgery who are subsequently admitted to the ICU or a similar high dependency unit. The primary endpoint is the incidence of AKI within 72 hours after surgery according to the KDIGO criteria. Secondary endpoints include use of renal replacement therapy (RRT), mortality during ICU and hospital stay, length of ICU and hospital stay and major adverse kidney events (combined endpoint consisting of persistent renal dysfunction, RRT and mortality) at day 90. Further, we will evaluate preoperative and intraoperative risk factors affecting the incidence of postoperative AKI. In an add-on analysis, we will assess urinary biomarkers for early detection of AKI. Ethics and dissemination EPIS-AKI has been approved by the leading Ethics Committee of the Medical Council North Rhine-Westphalia, of the Westphalian Wilhelms-University Münster and the corresponding Ethics Committee at each participating site. Results will be disseminated widely and published in peer-reviewed journals, presented at conferences and used to design further AKI-related trials. Trial registration number NCT04165369.

Production of Σ(1385)± and Ξ(1530)0 in proton–proton collisions at √s = 7 TeV

The production of the strange and double-strange baryon resonances (Σ(1385)±, Ξ(1530)0) has been measured at mid-rapidity (|y|<0.5) in proton–proton collisions at √s = 7 TeV with the ALICE detector at the LHC. Transverse momentum spectra for inelastic collisions are compared to QCD-inspired models, which in general underpredict the data. A search for the ϕ(1860) pentaquark, decaying in the Ξπ channel, has been carried out but no evidence is seen. © 2015, CERN for the benefit of the ALICE collaboration